Evidence map›Paper›PMID 34278231›Full record

ArticleHemaSphere2021

Antibody Response After Initial Vaccination for SARS-CoV-2 in Patients With Amyloidosis.

Efstathios Kastritis, Evangelos Terpos, Aimilia Sklirou, Foteini Theodorakakou, Despina Fotiou, Eleni-Dimitra Papanagnou, Tina Bagratuni, Nikolaos Kanellias, Maria Gavriatopoulou, Ioannis P Trougakos and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in HemaSphere, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Efstathios KastritisDepartment of Clinical Therapeutics, National and Kapodistrian University of Athens, Greece.
Evangelos TerposDepartment of Clinical Therapeutics, National and Kapodistrian University of Athens, Greece.
Aimilia SklirouDepartment of Cell Biology and Biophysics, Faculty of Biology, National and Kapodistrian University of Athens, Greece.
Foteini TheodorakakouDepartment of Clinical Therapeutics, National and Kapodistrian University of Athens, Greece.
Despina FotiouDepartment of Clinical Therapeutics, National and Kapodistrian University of Athens, Greece.
Eleni-Dimitra PapanagnouDepartment of Cell Biology and Biophysics, Faculty of Biology, National and Kapodistrian University of Athens, Greece.
Tina BagratuniDepartment of Clinical Therapeutics, National and Kapodistrian University of Athens, Greece.
Nikolaos KanelliasDepartment of Clinical Therapeutics, National and Kapodistrian University of Athens, Greece.
Maria GavriatopoulouDepartment of Clinical Therapeutics, National and Kapodistrian University of Athens, Greece.
Ioannis P TrougakosDepartment of Cell Biology and Biophysics, Faculty of Biology, National and Kapodistrian University of Athens, Greece.
Meletios A DimopoulosDepartment of Clinical Therapeutics, National and Kapodistrian University of Athens, Greece.
National and Kapodistrian University of Athens · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34278231
PMCPMC8280079
OpenAlexW3180943154

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.